Skip to main content
Log in

Prevalence and Pathogenesis of Sleep Apnea and Lung Disease in Acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Respiratory disorders are common and important complications in acromegaly. Patients suffering from acromegaly display a 1.6–3.3 fold increase in mortality rate, which is due to respiratory disorders in 25% of cases. In these patients, mortality for lung disease is 2–3 fold higher than in the general population. Every portion of the respiratory system may be involved. Deformities of facial bones, edema and hypertrophy of the mucosae and pharyngeal and laryngeal cartilages, enlargement of the tongue and inspiratory collapse of the hypopharinx, all may contribute to respiratory alterations. Nasal polyps, “hormonal rhinitis”, changes of the voice and snoring are common occurrences. Though rarely, a laryngocele may ensue. Pneumomegaly is frequently observed and, as suggested by functional studies, might be due to an increased number rather than volume of the alveoli. An obstructive respiratory syndrome caused by mucosal thickening of the upper airways and bronchi is observed in 25% of female and 70% of male patients. The sleep apnea syndrome (SAS) affects 60–70% of acromegalic patients. SAS may be of obstructive, central or mixed type. Obstructive SAS is the prevailing form in acromegaly. It is due to intermittent obstruction of upper airways with preserved activity of the respiratory center, as testified by the remarkable thoracic and abdominal respiratory efforts. The pathogenesis of the central type of SAS is more complex. Narrowing of the upper airways may induce reflex inhibition of the respiratory center. Moreover, increased GH levels and, possibly, defects in the somatostatinergic pathways, may increase the ventilatory response of the respiratory center to carbon dioxide, thereby leading to respiratory arrest. In the mixed type of SAS, the phenomena underlying the other two forms coexist. Oxygen desaturation concomitant with the apneic episodes accounts for the frequent nocturnal wakening and diurnal drowsiness. Among the clinical correlates of SAS, arterial hypertension is of particular interest due to the close correlation existing between the two disorders. Sleep deprivation related to SAS seems per se to favor the appearance of hypertension. Moreover, short lasting hypoxemia may induce prolonged elevations of blood pressure, mediated by decreased endothelial generation of nitric oxide. Thus, since cardiovascular events are the main cause of mortality in patients with acromegaly, it is reasonable to hypothesize that SAS is involved in the reduced life span of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Marie P. Sur deux cas d'acromègalie. Rev Med 1886;6:297–333.

    Google Scholar 

  2. Thomas SG, Woodhouse LJ, Pagura SM, Ezzat S. Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess. Clin Endocrinol 2002;56:351–358.

    Google Scholar 

  3. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab 1998;83:2730–2734.

    Google Scholar 

  4. Evans CC, Hipkin LJ, Murray GM. Pulmonary function in acromegaly. Q J Med 1977;32:322–327.

    Google Scholar 

  5. Grunstein RR, Ho KY, Sullivan CE. Sleep apnoea in acromegaly. Ann Intern Med 1991;115:527–532.

    Google Scholar 

  6. Weiss V, Sonka K, Pretl M, Dostàlova S, Klozar J, Rambousek P, Marek J, Haas T. Prevalence of sieep apnea syndrome in acromegaly population. J Endocrinol Invest 2000;23:515–519.

    Google Scholar 

  7. Lund VJ. International consensus report on the diagnosis and management of rhinitis. Allergy Suppl 1994;19:5–34.

    Google Scholar 

  8. Petruson B, Hansson H, Petruson K. Insulin like growth factor I immunoreactivity in nasal polyps. Arch Otolaryngol Head Neck Surg 1988;114:1272–1275.

    Google Scholar 

  9. Hansson H, Jorgensen F, Petruson B, Petruson K. Regenerating human nasal mucosa cells express peptide growth factors. Arch Otolaryngol Head Neck Surg 1991;117:1368–1377.

    Google Scholar 

  10. Motta S, Ferone D, Colao A, Merola B, Motta G, Lombardi G. Fixity of vocal cords and laryngocele in acromegaly. J Endocrinol Invest 1997;20:672–674.

    Google Scholar 

  11. Pelttari L, Polo O, Rauhala E, Vuoriluoto J, Aitasalo K, Hyyppa T, Kronholm E, Irjala K, Viikari J. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol 1995;43:175–182.

    Google Scholar 

  12. Brody JS, Fisher AB, Gocmen A, DuBois AB. Acromegalic pneumonomegaly: Lung growth in the adult. J Clin Invest 1970;49:1051–1060.

    Google Scholar 

  13. Trotman-Dickenson B, Weetman AP, Hughes JM. Upper airflow obstruction and pulmonary function in acromegaly. Relationship to disease activity. Q J Med 1991;79:527–538.

    Google Scholar 

  14. Pertinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992;15:1–4.

    Google Scholar 

  15. Bresnitz EA, Goldberg R, Kosinski RM. Epidemiology of obstructive sleep apnea. Epidemiol Rev 1994;16:210–227.

    Google Scholar 

  16. Hochban W, Ehlenz K, Conradt R, Brandenburg U. Obstructive sleep apnoea in acromegaly: The role of craniofacial changes. Eur Resp J 1999;14:196–202.

    Google Scholar 

  17. Isono S, Saeki N, Tanaka A, Nishino T. Collapsibility of passive pharynx in patients with acromegaly. Am J Respir Crit Care Med 1999;160:64–68.

    Google Scholar 

  18. Stevenaert A, Beckeras A. Presurgical octreotide treatment in acromegaly. Acta Endocrinol 1993;129(suppl 1):18–20.

    Google Scholar 

  19. Grunstein RR, Ho KY, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med 1994;121:478–483.

    Google Scholar 

  20. Douglas N. The sleep apnoea/hypopnoea syndrome and snoring. Br Med J 1993;306:1057–1060.

    Google Scholar 

  21. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly: Clinical and biochemical features in 500 patients. Medicine (Baltimore) 1994;73:233–240.

    Google Scholar 

  22. Blankfield RP, Tapolyai AA, Zyzanski SJ. Left ventricular dysfunction, pulmonary hypertension, obesity, and sleep apnea. Sleep Breath 2001;5:57–62.

    Google Scholar 

  23. Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hender J. Blood pressure, cardiac structure and seventy of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001;11:2071–2078.

    Google Scholar 

  24. Silverberg DS, Iaina A, Oksenberg A.Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Phys 2002;65:229–236.

    Google Scholar 

  25. Guilleminault C, Cummiskey J, Demment W. Sleep apnoea syndrome: Recent advances. Adv Intern Med 1980;26:347–372.

    Google Scholar 

  26. Silverberg DS, Oksenberg A, Radwan H, Iaina A. Is obstructive sleep apnea a common cause of essential hypertension?Isr J Med Sci 1995;31:527–535.

    Google Scholar 

  27. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: Facts and theory. Am J Med 1995;98:118–128.

    Google Scholar 

  28. Lavie P, Ben-Yosef R, Rubin A. Prevalence of sleep apnea syndrome in patients with essential hypertension. Am Heart J 1984;108:373–376.

    Google Scholar 

  29. Kales A, Bixler EO, Cadieux RJ, Schneck DW, Shaw LC III, Locke TW, Vela-Bueno A, Soldatos CR. Sleep apnoea in a hypertensive population. Lancet 1984;2:1005–1008.

    Google Scholar 

  30. Williams AJ, Houston D, Finberg S, Lam C, Kinney JL, Santiago S. Sleep apnea syndrome and essential hypertension. Am J Cardiol 1985;55:1019–1022.

    Google Scholar 

  31. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med1985;103:190–195.

    Google Scholar 

  32. Berger HA, Somers VK, Phillips BG. Sleep disordered breathing and hypertension. Curr Opin Pulm Med 2001;7:386–390.

    Google Scholar 

  33. Tilkian G, Guilleminault C, Schroeder JS. Sleep-induced apnea syndrome: Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977;63:348–355.

    Google Scholar 

  34. Shepard JW Jr, Garrison M, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985;88:335–340.

    Google Scholar 

  35. He J, Kryger M, Zorick F, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea: Experiences in 385 male patients. Chest 1988;94:9–14.

    Google Scholar 

  36. Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W, Heiss WD.Sleep apnoea in treated acromegaly: Relative frequency and predisposing factors. Clin Endocrinol 1996;45:563–569.

    Google Scholar 

  37. Rosenow F, McCarthy V, Caruso C. Sleep apnoea in endocrine diseases. J Sleep Res 1998;7:3–11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fatti, L.M., Scacchi, M., Pincelli, A.I. et al. Prevalence and Pathogenesis of Sleep Apnea and Lung Disease in Acromegaly. Pituitary 4, 259–262 (2001). https://doi.org/10.1023/A:1020702631793

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020702631793

Navigation